Asthma and Copd

A session at Asthma and Copd

  • Christine Ward
  • Dr Nithyanandan Nagercoil
  • Fan Chung
  • Noel Snell
  • Paul Whittaker

Wednesday 2nd April, 2014

8:30am to 4:40pm (GMT)

The global market for Asthma and COPD drugs is set to reach $47bn in 2017. There is a growing demand for the next generation of inhaled combination products and novel therapeutics.
Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.

Business Benefits for 2014:

  • New for 2014 - Four round table discussions to enhance networking capabilities between delegates and sponsors
  • Hear the latest regulatory advice from the MHRA on new inhaled drugs
  • Evaluate strategies to enhance clinical trial design with key talks from Teva and AstraZeneca
  • Listen to case studies from University College London and Theravance Inc. on the late stage developments of combination therapies
  • Gain insight on U-Biopred from committee members, Novartis, the British Lung Foundation and the National Heart and Lung Institute

The 10th annual event is now well known and established within the industry.
Comments from previous instalments include: "Excellent, both days" – Prosonix, "Good Networking opportunities" – Novartis

Category: Conferences/Trade show

Conference and workshop: £2098+vat
Conference Only: £1499+vat

About the speakers

This person is speaking at this event.
Christine Ward

Principal Scientist, Translational Medicine-RIA, MedImmune

This person is speaking at this event.
Dr Nithyanandan Nagercoil

Senior Medical Assessor, MHRA

This person is speaking at this event.
Fan Chung

Professor of Respiratory Medicine and Head of Experimental Studies Medicine, National Heart and Lung Institute

This person is speaking at this event.
Noel Snell

Director of Research, British Lung Foundation

This person is speaking at this event.
Paul Whittaker

Director/Unit Head for Pre-Clinical Biomarkers Respiratory Disease Area, Novartis

Sign in to add slides, notes or videos to this session

Asthma and Copd

England England, London

2nd3rd April 2014

Tell your friends!


Starts 2nd April 2014 at 8:30am GMT

Ends 3rd April 2014 at 4:40pm GMT

Session Hash Tag


Short URL


Official session page


View the schedule


See something wrong?

Report an issue with this session